LINDA MUEHL: Open Payments
NPI 1326018664 · FREDERICK, MD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$958 in 10 payments from 9 companies in 2025. Trend: 2023 $852 · 2024 $831 · 2025 $958
Food & beverage: $958
| Company | Payments | Amount |
|---|---|---|
| Amgen Inc. | 2 | $205 |
| Novo Nordisk Inc | 1 | $125 |
| Dexcom, Inc. | 1 | $115 |
| Teva Pharmaceuticals USA, Inc. | 1 | $103 |
| Phathom Pharmaceuticals, Inc. | 1 | $97 |
| Neurocrine BioSciences, Inc. | 1 | $83 |
| Sage Therapeutics, LLC | 1 | $80 |
| COLOPLAST CORP | 1 | $77 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $73 |
Products named: Wegovy, DEXCOM G7 GSS (161), REPATHA, AUSTEDO XR, KRYSTEXXA, VOQUEZNA, INGREZZA, Titan.
Industry payments across MD — which companies pay providers there.
